Michael P. Agius

1.3k total citations
14 papers, 332 citations indexed

About

Michael P. Agius is a scholar working on Molecular Biology, Hematology and Organic Chemistry. According to data from OpenAlex, Michael P. Agius has authored 14 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Hematology and 3 papers in Organic Chemistry. Recurrent topics in Michael P. Agius's work include Multiple Myeloma Research and Treatments (5 papers), Protein Degradation and Inhibitors (4 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Michael P. Agius is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Protein Degradation and Inhibitors (4 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Michael P. Agius collaborates with scholars based in United States and France. Michael P. Agius's co-authors include Scott J. Barraza, Yahira M. Báez-Santos, Andrew D. Mesecar, Scott D. Larsen, Susan C. Baker, Anna M. Mielech, Nicole D. Armstrong, Michael W. Wilson, C. Mathieu and Alexandre Detappe and has published in prestigious journals such as Angewandte Chemie International Edition, Blood and Nature Nanotechnology.

In The Last Decade

Michael P. Agius

12 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael P. Agius United States	7	138	100	88	59	47	14	332
Achyut Dahal United States	9	185 1.3×	102 1.0×	45 0.5×	33 0.6×	87 1.9×	16	390
Yanhui Zheng China	6	170 1.2×	127 1.3×	46 0.5×	14 0.2×	41 0.9×	11	451
Pablo R. Arantes United States	13	317 2.3×	37 0.4×	39 0.4×	29 0.5×	36 0.8×	31	437
M. Błaszczyk United Kingdom	11	258 1.9×	65 0.7×	42 0.5×	116 2.0×	34 0.7×	20	407
Ioannis Galdadas United Kingdom	11	207 1.5×	72 0.7×	39 0.4×	21 0.4×	14 0.3×	14	441
Mukesh Mahajan United States	14	296 2.1×	40 0.4×	25 0.3×	33 0.6×	38 0.8×	22	439
Byung Ju Kim Canada	10	198 1.4×	26 0.3×	33 0.4×	46 0.8×	50 1.1×	14	326
Mohamad Reza Ganjalikhany Iran	12	327 2.4×	39 0.4×	41 0.5×	24 0.4×	19 0.4×	27	443
Hiyun Kim United States	9	194 1.4×	45 0.5×	57 0.6×	88 1.5×	35 0.7×	10	347
Enming Xing United States	9	140 1.0×	49 0.5×	26 0.3×	26 0.4×	21 0.4×	19	272

Countries citing papers authored by Michael P. Agius

Since Specialization

Citations

This map shows the geographic impact of Michael P. Agius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Agius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Agius more than expected).

Fields of papers citing papers by Michael P. Agius

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. Agius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Agius. The network helps show where Michael P. Agius may publish in the future.

Co-authorship network of co-authors of Michael P. Agius

This figure shows the co-authorship network connecting the top 25 collaborators of Michael P. Agius. A scholar is included among the top collaborators of Michael P. Agius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael P. Agius. Michael P. Agius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Agius, Michael P., N. Connor Payne, Qi Liu, et al.. (2024). Pharmacological Targeting of IRF4 As a Therapeutic Strategy for Multiple Myeloma. Blood. 144(Supplement 1). 155–155. 1 indexed citations

Sklavenitis‐Pistofidis, Romanos, Ting Wu, Elizabeth D. Lightbody, et al.. (2024). Single-Cell RNA-Sequencing of 6 Million Tumor and Immune Cells in 365 Patients with MGUS and SMM Demonstrates Complex Progressive Changes in Immune Cell Functionality with a Distinct Footprint on Tumor Cell Biology and Disease Control. Blood. 144(Supplement 1). 1895–1895.

Detappe, Alexandre, Hung V.‐T. Nguyen, Yivan Jiang, et al.. (2023). Molecular bottlebrush prodrugs as mono- and triplex combination therapies for multiple myeloma. Nature Nanotechnology. 18(2). 184–192. 68 indexed citations

Agius, Michael P., et al.. (2022). Conformation-tunable ATP-competitive kinase inhibitors. Chemical Communications. 58(21). 3541–3544. 2 indexed citations

Johnson, Taylor K., et al.. (2021). Synergy and Antagonism between Allosteric and Active‐Site Inhibitors of Abl Tyrosine Kinase. Angewandte Chemie International Edition. 60(37). 20196–20199. 15 indexed citations

Johnson, Taylor K., et al.. (2021). Synergy and Antagonism between Allosteric and Active‐Site Inhibitors of Abl Tyrosine Kinase. Angewandte Chemie. 133(37). 20358–20361. 1 indexed citations

Rahmat, Mahshid, Kendell Clement, Romanos Sklavenitis‐Pistofidis, et al.. (2021). Identification of a Novel Epigenetic Mechanism of MYC Deregulation in Smoldering and Newly Diagnosed Multiple Myeloma Patients. Blood. 138(Supplement 1). 504–504.

Detappe, Alexandre, C. Mathieu, Caining Jin, et al.. (2020). Anti-MUC1-C Antibody–Conjugated Nanoparticles Potentiate the Efficacy of Fractionated Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 108(5). 1380–1389. 20 indexed citations

Nguyen, Hung V.‐T., Alexandre Detappe, Peter Harvey, et al.. (2020). Pro-organic radical contrast agents (“pro-ORCAs”) for real-time MRI of pro-drug activation in biological systems. Polymer Chemistry. 11(29). 4768–4779. 24 indexed citations

10.

Lightbody, Elizabeth D., Mairéad Reidy, Michael P. Agius, et al.. (2019). A High-Throughput Drug Screen Reveals a Novel Compound Class That Significantly Depletes IRF4 Expression in Multiple Myeloma. Blood. 134(Supplement_1). 5545–5545. 2 indexed citations

11.

Agius, Michael P., et al.. (2019). Selective Proteolysis to Study the Global Conformation and Regulatory Mechanisms of c-Src Kinase. ACS Chemical Biology. 14(7). 1556–1563. 12 indexed citations

12.

Detappe, Alexandre, Hung V.‐T. Nguyen, C. Mathieu, et al.. (2018). A Rationally Designed Novel Polymer for Safe and Synergistic Delivery of High Dose Bortezomib, Pomalidomide/Lenalidomide, and Dexamethasone for Multiple Myeloma. Blood. 132(Supplement 1). 4681–4681. 1 indexed citations

13.

Báez-Santos, Yahira M., Scott J. Barraza, Michael W. Wilson, et al.. (2014). X-ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of Human Coronavirus Papain-like Proteases. Journal of Medicinal Chemistry. 57(6). 2393–2412. 168 indexed citations

14.

Bender, Aaron M., Mary J. Clark, Michael P. Agius, John R. Traynor, & Henry I. Mosberg. (2013). Synthesis and evaluation of 4-substituted piperidines and piperazines as balanced affinity μ opioid receptor (MOR) agonist/δ opioid receptor (DOR) antagonist ligands. Bioorganic & Medicinal Chemistry Letters. 24(2). 548–551. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact